Exhibit 10.10

Execution Version


 


SECURITIES PURCHASE AGREEMENT


 


This SECURITIES PURCHASE
AGREEMENT (the “Agreement”), dated as of April 25, 2022, is by and among Pareteum Corporation, a Delaware corporation
with offices located at 1185 Avenue of the Americas, 2nd Floor, New York, NY 10036 (the “Company”), and the investor
listed on the Schedule of Buyers attached hereto (the “Buyer”), as such Schedule of Buyers may be supplemented from
time to time pursuant to the terms hereof.


 


RECITALS


 


A.    The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule 506(b) of Regulation
D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”)
under the 1933 Act.


 


B.     The Company has authorized the issuance of a new series of 8.00% Senior Secured Bridge Notes (the “Bridge Notes”)
in the form attached hereto as Exhibit A to be issued at the Bridge Closing (as defined below; and together with any such
Bridge Note issued in exchange for any thereof, collectively, the “Bridge Notes”).


 


C.     The Company had, prior to the date hereof, authorized three series of 8.00% senior convertible notes (the “Convertible
Notes”) pursuant to the Existing Note Documents (as defined in the Bridge Notes), which Convertible Notes were previously convertible
into shares of the Company’s common stock, par value $0.00001 per share (together with any capital stock into which such common
stock shall have been changed or any share capital resulting from a reclassification of such common stock, the “Common Stock”)
(such underlying shares of Common Stock issuable pursuant to the terms of the Convertible Notes, the “Conversion Shares”).
As of the date hereof, Convertible Notes are no longer subject to conversion into the Conversion Shares.


 


D.     The Company had, prior to the date hereof, authorized the issuance of Warrants to purchase Common Stock pursuant to the Existing
Note Documents (the “Warrants”), which Warrants were exercisable for shares of Common Stock in accordance with the
terms thereof (such underlying shares of Common Stock issuable upon exercise of a Warrant, collectively, the “Warrant Shares”
and, together with the Conversion Shares, the “Underlying Shares”). As of the date hereof, the Warrants have been terminated.


 


E.      The Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, the aggregate
principal amount of the Bridge Notes set forth opposite the Buyer’s name in column (3) on the Schedule of Buyers. For the avoidance
of doubt, the Bridge Notes will not be convertible into Common Stock and the Company is not issuing Warrants to purchase Common Stock
to the Bridge Note Buyer.


 


F.      At the Closing, the parties hereto shall execute and deliver (i) a Security Agreement, in the form attached hereto as Exhibit
C (the “Security Agreement”), pursuant to which the Company has agreed to grant a first priority security interest
to the holders of the Bridge Notes in substantially all of its assets and (ii) a European Security Agreement, (the “European
Security Agreement”), pursuant to which certain of the Company’s European subsidiaries have agreed to grant a first priority
security interest to the holders of the Bridge Notes in substantially all of their assets.


 






     


     


    

 


G.    The Bridge Notes are also referred to herein as the “Purchased Securities” and the “Securities.”


 


AGREEMENT


 


NOW, THEREFORE, in consideration
of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Company and the Buyer hereby agree as follows:


 


		1.	PURCHASE AND SALE OF PURCHASED SECURITIES.



 


(a)   Purchase of Purchased Securities.  The Company shall issue and sell to the Buyer, and the Buyer agrees to purchase
from the Company on a Closing Date (as defined below) the aggregate principal amount of the Bridge Notes as set forth opposite the Buyer’s
name in column (3) of the Schedule of Buyers; and


 


(b)   Closing.  The closing of the purchase of the Bridge Notes (the “Bridge Closing”) shall occur at
the offices of DLA Piper LLP (US), 1251 Avenue of the Americas, 27th Floor, New York, New York, 10020. The date and time of the Bridge
Closing (the “Bridge Closing Date”) shall be 9:00 a.m. on April 25, 2022.


 


(c)   Securities Purchase Price.  The aggregate purchase price for the Purchased Securities to be purchased by the Buyer
(the “Purchase Price”) shall be the amount set forth opposite the Buyer’s name in column (7) of the Schedule
of Buyers.


 


(d)   Form of
Initial Payment for Purchased Securities.  On the Closing Date (i) the Buyer shall pay the Purchase Price to the
Company for the Purchased Securities to be issued and sold to the Buyer at Closing set forth opposite the Buyer’s name on the
Schedule of Buyers on such Closing Date, by wire transfer of immediately available funds in accordance with a letter on the
letterhead of the Company, duly executed by a duly authorized officer of the Company, setting forth the wire amounts of such Buyer
and the wire transfer instructions of the Company (the “Flow of Funds Letter”) and (ii) the Company shall
deliver to the Buyer the aggregate principal amount of Bridge Notes as is set forth opposite the Buyer’s name in column (3) of
the Schedule of Buyers, duly executed on behalf of the Company and registered in the name of the Buyer or its designee; and


 


(e)     Withholding Rights. Notwithstanding any other provision of the Transaction Documents to the contrary, the Company
shall be entitled to deduct and withhold from any amount otherwise payable with respect to the Purchased Securities such amounts as the
Company is required to deduct and withhold under any provision of the Code or any applicable law related to Taxes. Any such withheld amounts
shall be treated for all purposes of this Agreement and the Transaction Documents as having been paid to the Person in respect of whom
such deduction and withholding was made.


 






    	 	2	 



     


    

 


		2.	BUYER’S REPRESENTATIONS AND WARRANTIES.



 


The Buyer represents and warrants
to the Company that, as of the date hereof:


 


(a)    Organization; Authority.  The Buyer is an entity duly organized, validly existing and in good standing under the laws
of Singapore with the requisite power and authority to conduct its business as currently conducted and enter into and to consummate the
transactions contemplated by the Transaction Documents (as defined below) to which it is a party and otherwise to carry out its obligations
hereunder and thereunder.


 


(b)    No Public Sale or Distribution. The Buyer is acquiring the Bridge Notes for its own account and not with a view towards,
or for resale in connection with, the public sale or distribution thereof in violation of applicable securities laws, except pursuant
to sales registered or exempted under the 1933 Act; provided, however, by making the representations herein, the Buyer does not agree,
or make any representation or warranty, to hold any of the Securities for any minimum or other specific term and reserves the right to
dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption from registration under
the 1933 Act. The Buyer does not presently have any agreement or understanding, directly or indirectly, with any Person to distribute
any of the Securities in violation of applicable securities laws. For purposes of this Agreement, “Person” means an
individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other
entity and any Governmental Entity (as defined below) or any department or agency thereof.


 


(c)    Accredited Investor Status. At the time the Buyer was offered the Securities, it was and, as of the date hereof, is, an
 “accredited investor” as that term is defined in Rule 501(a) of Regulation D.


 


(d)    Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part
upon the truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer
to acquire the Securities.


 


(e)    Information. The Buyer and its advisors have been furnished with all materials relating to the business, finances and operations
of the Company and materials relating to the offer and sale of the Securities that have been requested by the Buyer. The Buyer and its
advisors have had (i) the opportunity to review the Transaction Documents and the SEC Documents (as defined below) and has been afforded
the opportunity to ask such questions of the Company as it has deemed necessary of, and to receive answers from, representatives of the
Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities;
(ii) access to information about the Company and its financial condition, results of operations, business, properties, management and
prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the
Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with
respect to the investment (and neither such inquiries nor any other due diligence investigations conducted by the Buyer or its advisors
or representatives shall modify, amend or affect the Buyer’s right to rely on the Company’s representations and warranties
contained herein). The Buyer (A) understands that its investment in the Securities involves a high degree of risk; (B) acknowledges that
it can bear the economic risk and complete loss of its investment in the Securities and has such knowledge and experience in financial
or business matters that it is capable of evaluating the merits and risks of the investment contemplated hereby; (C) did not learn of
the investment in the Securities as a result of any general solicitation or general advertising; (D) has sought such accounting, legal
and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities;
and (E) is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, except for statements,
representations and warranties contained in this Agreement, in making its investment or decision to invest in the Company.


 






    	 	3	 



     


    

 


(f)    No Governmental Review. The Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the
Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.


 


(g)   Transfer or Resale. The Buyer understands that: (i) the Securities have not been and are not being registered under the
1933 Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered
thereunder, (B) the Buyer shall have delivered to the Company (if requested by the Company) an opinion of counsel with expertise in U.S.
federal securities laws, in a form reasonably acceptable to the Company, to the effect that such Securities to be sold, assigned or transferred
may be sold, assigned or transferred pursuant to an exemption from such registration, or (C) the Buyer provides the Company with reasonable
assurance that such Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated under the 1933 Act (or
a successor rule thereto) (collectively, “Rule 144”); (ii) any sale of the Securities made in reliance on Rule 144
may be made only in accordance with the terms of Rule 144, and further, if Rule 144 is not applicable, any resale of the Securities under
circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined
in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC promulgated
thereunder; provided, that, from and after the date that is six (6) months following the date hereof, at the request of Buyer, the Company
shall, if the Company is then in compliance with Section 4(c) hereof, deliver to Buyer or the Company’s transfer agent, as applicable,
an opinion of counsel to the Company, at the Company’s expense and in a form reasonably acceptable to the Buyer, that (i) adequate
public information with respect to the Company is then available (within the meaning of Rule 144(c)) and (ii) that a sale of the Securities
may otherwise be made in accordance with the terms of Rule 144; and (iii) neither the Company nor any other Person is under any obligation
to register the Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions of any exemption
thereunder. Notwithstanding the foregoing, the Securities may be pledged in connection with a bona fide margin account or other loan or
financing arrangement secured by the Securities and such pledge of Securities shall not be deemed to be a transfer, sale or assignment
of the Securities hereunder, and the Buyer effecting a pledge of Securities shall not be required to provide the Company with any notice
thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document (as defined in Section
3(b)), including, without limitation, this Section 2(g).


 






    	 	4	 



     


    

 


(h)   Validity; Enforcement.  This Agreement, the Security Agreement and the Security Documents (as defined in the Security
Agreement) have been duly and validly authorized, executed and delivered on behalf of the Buyer and shall constitute the legal, valid
and binding obligations of the Buyer enforceable against the Buyer in accordance with their respective terms, except as such enforceability
may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other
similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.


 


(i)    No Conflicts.  The execution, delivery and performance by the Buyer of this Agreement, the Security Agreement and the
Security Documents and the consummation by the Buyer of the transactions contemplated hereby and thereby will not (i) result in a
violation of the organizational documents of the Buyer, or (ii) conflict with, or constitute a default (or an event which with notice
or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which the Buyer is a party, or (iii) result in a violation of any law, rule, regulation,
order, judgment or decree (including federal and state securities laws) applicable to the Buyer, except in the case of clauses (ii) and
(iii) above, for such conflicts, defaults, rights or violations which could not, individually or in the aggregate, reasonably be
expected to have a material adverse effect on the ability of the Buyer to perform its obligations hereunder.


 


(j)    No Bad Actor Disqualification Event.  The Buyer represents, after reasonable inquiry, that none of the “Bad Actor”
disqualifying events described in Rule 506(d)(l)(i) to (viii) under the 1933 Act (a “Disqualification Event”) is applicable
to Buyer or any of its Rule 506(d) Related Parties (if any). “Rule 506(d) Related Party” means a person or entity that
is a beneficial owner of the Buyer’s securities for purposes of Rule 506(d).


 


		3.	REPRESENTATIONS AND WARRANTIES OF THE COMPANY.



 


The Company represents and
warrants to the Buyer as of the date hereof, except as otherwise disclosed by the Company to the Buyer on or before the date hereof (each
reference to any Schedule in this Section 3, being a reference to the comparable such Schedule in the Existing Note Documents,
each as previously disclosed by the Company to the Buyer), that:


 


(a)   Organization and Qualification.  Each of the Company and each of its Subsidiaries are entities duly organized and validly
existing and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite power and authority
to own their properties and to carry on their business as now being conducted.  Each of the Company and each of its Subsidiaries
is duly qualified as a foreign entity to do business and is in good standing in every jurisdiction in which its ownership of property
or the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified
or be in good standing would not reasonably be expected to have a Material Adverse Effect (as defined below).  As used in this Agreement,
 “Material Adverse Effect” means any material adverse effect on (i) the business, properties, assets, liabilities,
operations (including results thereof), or condition (financial or otherwise) of the Company and its Subsidiaries, taken as a whole, (ii) the
transactions contemplated hereby or in any of the other Transaction Documents or any other agreements or instruments to be entered into
in connection herewith or therewith or (iii) the authority or ability of the Company or any of its Subsidiaries to perform any of
their respective obligations under any of the Transaction Documents.  Other than the Persons (as defined below) set forth on Schedule 3(a)
(the “Significant Subsidiaries” and each is individually referred to herein as a “Significant Subsidiary”),
the Company has no significant Subsidiaries within the meaning of Rule 1-02(w) of Regulation S-X.  “Subsidiaries”
means any Person in which the Company, directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or similar
interest of such Person or (II) controls or operates all or any part of the business, operations or administration of such Person, and
each of the foregoing, is individually referred to herein as a “Subsidiary.”


 






    	 	5	 



     


    

 


(b)   Authorization; Enforcement; Validity.  The Company has the requisite power and authority to enter into and perform
its obligations under this Agreement and the other Transaction Documents and to issue the Securities in accordance with the terms hereof
and thereof.  Each Subsidiary has the requisite power and authority to enter into and perform its obligations under the Transaction
Documents to which it is a party.  The execution and delivery of this Agreement and the other Transaction Documents by the Company,
and the consummation by the Company and its Subsidiaries of the transactions contemplated hereby and thereby have been duly authorized
by the Company’s board of directors (the “Board of Directors”), and (other than (i) any filings as may be
required by any state securities agencies (the “Required Filings”)) no further filing, consent or authorization is
required by the Company, its Subsidiaries, their respective boards of directors or their stockholders or other governing body.  This
Agreement and the other Transaction Documents have been duly executed and delivered by the Company, and each constitutes the legal, valid
and binding obligations of the Company, enforceable against the Company in accordance with its respective terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification
and to contribution may be limited by federal or state securities law.  “Transaction Documents” means, collectively,
this Agreement, the Bridge Notes, the Security Agreement, the Security Documents, and each of the other agreements and instruments entered
into or delivered by any of the parties hereto in connection with the transactions contemplated hereby and thereby, as may be amended
from time to time.


 


(c)   Issuance of Securities.  The issuance of the Securities is duly authorized and when issued and delivered in accordance
with the terms of the Transaction Documents the Securities shall be validly issued and free from all preemptive or similar rights, mortgages,
defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances (collectively
 “Liens”) with respect to the issuance thereof.  Subject to the accuracy of the representations and warranties
of the Buyer in the Transaction Documents, the offer and issuance by the Company of the Securities is exempt from registration under the
1933 Act.


 


(d)   No Conflicts.  The execution, delivery and performance of the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Bridge Notes) will
not (i) result in a violation of the Certificate of Incorporation (as defined below), Bylaws (as defined below), certificate of formation,
memorandum of association, articles of association, bylaws or other organizational documents of the Company or any of its Subsidiaries,
or any capital stock or other securities of the Company or any of its Subsidiaries, (ii) upon receipt of applicable consents under
the Existing Note Documents, conflict with, or constitute a default (or an event which with notice or lapse of time or both would become
a default) in any respect under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) assuming the accuracy of the representations
and warranties in Section 2, result in a violation of any law, rule, regulation, order, judgment or decree (including, without limitation,
foreign, federal and state securities laws and regulations and including all applicable foreign, federal and state laws, rules and
regulations) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries
is bound or affected, assuming, with respect to clauses (ii) and (iii) above, the making of the Required Filings and except in the
case of clauses (ii) and (iii) above, for such breaches, violations or conflicts as would not reasonably be expected, individually
or in the aggregate, to have a Material Adverse Effect.


 






    	 	6	 



     


    

 


(e)  Consents.  Except as provided in the Existing Note Documents, neither the Company nor any Subsidiary is required to
obtain any consent from, authorization or order of, or make any filing or registration with (other than the Required Filings and such
consents, authorizations, filings or registrations the absence of which would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect), any Governmental Entity or any regulatory or self-regulatory agency or any other Person in order for
it to execute, deliver or perform any of its respective obligations under or contemplated by the Transaction Documents, in each case,
in accordance with the terms hereof or thereof.  To the Company’s knowledge, other than the Required Filings and those required
under the Existing Note Documents, all consents, authorizations, orders, filings and registrations which the Company or any Subsidiary
is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the Closing Date, and, to the Company's
knowledge, neither the Company nor any of its Subsidiaries are aware of any facts or circumstances which might prevent the Company or
any of its Subsidiaries from obtaining or effecting any of the registration, application or filings contemplated by the Transaction Documents. 
 “Governmental Entity” means any nation, state, county, city, town, village, district, or other political jurisdiction
of any nature, federal, state, local, municipal, foreign, or other government, governmental or quasi-governmental authority of any nature
(including any governmental agency, branch, department, official, or entity and any court or other tribunal), multi-national organization
or body; or body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing
authority or power of any nature or instrumentality of any of the foregoing, including any entity or enterprise owned or controlled by
a government or a public international organization or any of the foregoing. Where used under this Agreement with respect to the Company,
the term “knowledge” shall mean the actual knowledge of Bart Weijermars, Alexander Korff and/or Laura W. Thomas after
due and reasonable inquiry.


 


(f)   Acknowledgment Regarding Buyer’s Purchase of Securities.  The Company acknowledges and agrees that the Buyer
is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated
hereby and thereby and the Buyer is not (i) an officer or director of the Company or any of its Subsidiaries, (ii) to the Company’s
knowledge, an “affiliate” (as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) to the Company’s
knowledge, a “beneficial owner” of more than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3
of Securities Exchange Act of 1934, as amended (the “1934 Act”)).  The Company further acknowledges that Buyer
is not acting as a financial advisor or fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect
to the Transaction Documents and the transactions contemplated hereby and thereby, and any advice given by the Buyer or any of its representatives
or agents in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to the
Buyer’s purchase of the Securities.  The Company further represents to the Buyer that the Company’s and each Subsidiary’s
decision to enter into the Transaction Documents to which it is a party has been based solely on the independent evaluation by the Company,
each Subsidiary and their respective representatives.


 






    	 	7	 



     


    

 


(g)   No General Solicitation; No Placement Agent.  Neither the Company, nor any of its Subsidiaries or affiliates, nor any
Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation
D) in connection with the offer or sale of the Securities. Neither the Company nor any of its Subsidiaries has engaged any placement agent
or other agent in connection with the offer or sale of the Securities. The Company shall pay, and hold the Buyer harmless against, any
liability, loss or expense (including, without limitation, attorney’s fees and reasonable and documented out-of-pocket expenses)
arising in connection with any claim for the payment of any placement agent’s fees, financial advisory fees, or brokers’ commissions
(other than for Persons engaged by any Buyer) relating to or arising out of the transactions contemplated hereby. Schedule 3(g)
sets forth all placement agent’s fees, financial advisory fees, brokers’ commissions and any other payments that will become
owed, due and/or payable upon the closing of, or relating to or arising out of, the transactions contemplated hereby (other than for Persons
engaged by the Buyer) that are payable by the Company or any of its Subsidiaries.


 


(h)   No Integrated Offering.  None of the Company, its Subsidiaries or any of their affiliates, nor any Person acting on
their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under
circumstances that would require registration of the issuance of any of the Securities under the 1933 Act, whether through integration
with prior offerings or otherwise, or cause this offering of the Securities to require approval of stockholders of the Company in connection
with the offering of the Securities for purposes of the 1933 Act or under any applicable stockholder approval provisions, including, without
limitation, under the rules and regulations of any exchange or automated quotation system on which any of the securities of the Company
are listed or designated for quotation.  None of the Company, its Subsidiaries, their affiliates nor any Person acting on their behalf
will take any action or steps that would require registration of the issuance of any of the Securities under the 1933 Act or cause the
offering of any of the Securities to be integrated with other offerings of securities of the Company.


 


(i)    [RESERVED].


 


(j)    Application of Takeover Protections.  The Company and its Board of Directors have taken all necessary action, if any,
in order to render inapplicable any control share acquisition, interested stockholder, business combination, poison pill, stockholder
rights plan or other similar anti-takeover provision under the Certificate of Incorporation, Bylaws or other organizational documents
or the laws of the jurisdiction of its incorporation which is or could become applicable to any Buyer as a result of the transactions
contemplated by this Agreement, including, without limitation, the Company’s issuance of the Securities and the Buyer’s ownership
of the Securities. 


 






    	 	8	 



     


    

 


(k)   [RESERVED].


 


(l)    [RESERVED].  


 


(m)  [RESERVED].


 


(n)   [RESERVED].


 


(o)   Foreign Corrupt Practices.  Neither the Company, any of the Subsidiaries, nor, any director, officer, employee thereof
nor, to the Company’s knowledge, any agent or any other person acting for or on behalf of the foregoing (individually and collectively,
a “Company Affiliate”) have violated the U.S. Foreign Corrupt Practices Act or any other applicable anti-bribery or
anti-corruption laws, nor, to the Company’s knowledge, has any Company Affiliate offered, paid, promised to pay, or authorized the
payment of any money, or offered, given, promised to give, or authorized the giving of anything of value, to any officer, employee or
any other person acting in an official capacity for any Governmental Entity to any political party or official thereof or to any candidate
for political office (individually and collectively, a “Government Official”) or to any person under circumstances
where such Company Affiliate knew or was aware of a high probability that all or a portion of such money or thing of value would be offered,
given or promised, directly or indirectly, to any Government Official, for the purpose of:


 


(i)   (A) influencing any act or decision of such Government Official in his/her official capacity, (B) inducing such Government
Official to do or omit to do any act in violation of his/her lawful duty, (C) securing any improper advantage, or (D) inducing
such Government Official to influence or affect any act or decision of any Governmental Entity, or


 


(ii)  assisting the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company
or its Subsidiaries.


 


(p)    Sarbanes-Oxley Act.  Except as set forth on Schedule 3(p), the Company and each Subsidiary is in material
compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, and any and all applicable rules and
regulations promulgated by the SEC thereunder.


 


(q)    Transactions With Affiliates.  Except as set forth on Schedule 3(q) or as disclosed on SEC Documents, no current
or former employee, partner, director, officer or shareholder (direct or indirect) of the Company or its Subsidiaries (other than the
Company or any Subsidiaries), or, to the Company's knowledge, no associate or affiliate of any thereof (other than the Company or any
Subsidiaries), or any relative with a relationship no more remote than first cousin of any of the foregoing, is presently, or has been,
since January 1, 2017, (i) a party to any transaction with the Company or its Subsidiaries (including any contract, agreement or other
arrangement providing for the furnishing of services by, or rental of real or personal property from, or otherwise requiring payments
to, any such director, officer or shareholder or such associate or affiliate or relative Subsidiaries (other than for ordinary course
services as employees, officers or directors of the Company or any of its Subsidiaries)) or (ii) the direct or indirect owner of an interest
in any corporation, firm, association or business organization which is a competitor, supplier or customer of the Company or its Subsidiaries,
nor does any such Person receive income from any source other than the Company or its Subsidiaries which relates to the business of the
Company or its Subsidiaries or should properly accrue to the Company or its Subsidiaries. No such employee, officer, shareholder or director
of the Company or any of its Subsidiaries or member of his or her immediate family is indebted to the Company or its Subsidiaries, as
the case may be, nor is the Company or any of its Subsidiaries indebted (or committed to make loans or extend or guarantee credit) to
any of them, other than (i) for payment of salary for services rendered, (ii) reimbursement for reasonable expenses incurred on behalf
of the Company, and (iii) for other standard employee benefits made generally available to all employees or executives (including share
option agreements outstanding under any share option plan approved by the Board of Directors of the Company).


 






    	 	9	 



     


    

 


(r)    Organizational Documents.


 


Organizational Documents. 
The Company has furnished to the Buyer true, correct and complete copies of the Company’s Certificate of Incorporation, as amended
and as in effect on the date hereof (the “Certificate of Incorporation”), and the Company’s bylaws, as amended
and as in effect on the date hereof (the “Bylaws”), and the material terms of all Convertible Securities and the material
rights of the holders thereof in respect thereto.


 


(s)   Indebtedness and Other Contracts.  Except for the Existing Note Documents and as set forth on Schedule 3(s),
neither the Company nor any of its Subsidiaries (i) has any material outstanding debt securities, notes, credit agreements, credit
facilities or other agreements, documents or instruments evidencing Indebtedness of the Company or any of its Subsidiaries or by which
the Company or any of its Subsidiaries is or may become bound, (ii) has any financing statements securing obligations in any amounts
filed in connection with the Company or any of its Subsidiaries; (iii) [Reserved], or (iv) is a party to any contract, agreement
or instrument relating to any Indebtedness, the performance of which, in the judgment of the Company’s officers, has or is expected
to have a Material Adverse Effect.  The Company is in default under each Existing Note Document. Neither the Company nor any of its
Subsidiaries have any liabilities or obligations required to be disclosed in the SEC Documents which are not so disclosed in the SEC Documents,
other than those incurred in the ordinary course of the Company’s or its Subsidiaries’ respective businesses consistent with
past practices and as disclosed to Buyer.  For purposes of this Agreement:  (x) “Indebtedness” has the
meaning set forth in the Bridge Notes; and (y) “Contingent Obligation” means, as to any Person, any direct or
indirect liability, contingent or otherwise, of that Person with respect to any Indebtedness, lease, dividend or other obligation of another
Person if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance
to the obligee of such liability that such liability will be paid or discharged, or that any agreements relating thereto will be complied
with, or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto.


 


(t)    Litigation.  Except as disclosed to Buyer and as set forth on Schedule 3(t), there is no material action, suit,
arbitration, proceeding, or, to the Company’s knowledge, any court, public board, other Governmental Entity, self-regulatory organization
or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, the Common
Stock or any of the Company’s or its Subsidiaries’ officers or directors, whether of a civil or criminal nature or otherwise,
in their capacities as such, except as set forth in Schedule 3(t).  To the knowledge of the Company, no director, officer
or employee of the Company or any of its Subsidiaries has willfully violated 18 U.S.C. §1519 or engaged in spoliation in reasonable
anticipation of litigation.  Without limitation of the foregoing, except as set forth on Schedule 3(t), there has not been,
and to the knowledge of the Company, there is not pending, contemplated or anticipated, any inquiry or investigation by the SEC involving
the Company, any of its Subsidiaries or any current or former director or officer of the Company or any of its Subsidiaries.  The
SEC has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company under
the 1933 Act or the 1934 Act.  After reasonable inquiry of its officers (as defined in Rule 16a-1(f) promulgated under
the 1934 Act) and members of its Board of Directors, except as set forth on Schedule 3(t), to the Company’s knowledge there
is no fact which might result in or form the basis for any such action, suit, arbitration, investigation, inquiry or other proceeding. 
Neither the Company nor any of its Subsidiaries is subject to any order, writ, judgment, injunction, decree, determination or award of
any Governmental Entity.


 






    	 	10	 



     


    

 


(u)   Insurance.  The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses
in which the Company and its Subsidiaries are engaged. Neither the Company nor any of its Subsidiaries has been refused any insurance
coverage sought or applied for, and neither the Company nor any of its Subsidiaries has any reason to believe that it will be unable to
renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be
necessary to continue its business at a cost that would not have a Material Adverse Effect.


 


(v)   Employee Relations.  Except as set forth on Schedule 3(v), neither the Company nor any of its U.S. Subsidiaries
is a party to any collective bargaining agreement or employs any member of a union.  To the knowledge of the Company, no executive
officer or other key employee of the Company or any of its Subsidiaries is, or is now expected to be, in violation of any material term
of any employment contract, confidentiality, disclosure or proprietary information agreement, non-competition agreement, or any other
contract or agreement or any restrictive covenant, and the continued employment of each such executive officer or other key employee (as
the case may be) does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. 
The Company and its Subsidiaries are in material compliance with all applicable federal, state, local and foreign laws and regulations
respecting labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except where
failure to be in compliance would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse
Effect.


 


(w)  Title. Each of the Company and its Subsidiaries holds good title to, or a valid leasehold interest in, all real property,
leases in real property, facilities or other interests in real property owned or held by the Company or any of its Subsidiaries that is
material to the business of the Company (the “Real Property”).  The Real Property is free and clear of all Liens
and is not subject to any rights of way, building use restrictions, exceptions, variances, reservations, or limitations of any nature
except for (a) Liens for current taxes not yet due and payable, (b) zoning laws and other land use restrictions that do not
impair the present or anticipated use of the property subject thereto and (c) those that are not likely to result in a Material Adverse
Effect.  Any Real Property held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting and
enforceable leases with such exceptions as are not material and do not interfere in any material respect with the use made and proposed
to be made of such property and buildings by the Company or any of its Subsidiaries.


 






    	 	11	 



     


    

 


(x)   Fixtures and Equipment.  Each of the Company and its Subsidiaries (as applicable) has good title to, or a valid leasehold
interest in, all material tangible personal property, equipment, improvements, fixtures, and other personal property and appurtenances
that are used by the Company or its Subsidiary in connection with the conduct of its business (the “Fixtures and Equipment”).
Each of the Company’s and its Subsidiary’s Fixtures and Equipment are structurally sound, are in good operating condition
and repair, are adequate for the uses to which they are being put, are not in need of maintenance or repairs except for ordinary, routine
maintenance and repairs and are sufficient for the conduct of the Company’s and/or its Subsidiaries’ businesses (as applicable)
in the manner as conducted prior to the Closing. Except as set forth on Schedule 3(x), each of the Company and its Subsidiaries
owns all of its Fixtures and Equipment free and clear of all Liens except for (i) Liens for current taxes not yet due and payable, (ii)
zoning laws and other land use restrictions that do not impair the present or anticipated use of the property subject thereto and (iii)
other Permitted Liens (as defined in the Bridge Notes).


 


(y)  Intellectual Property Rights.  Except as set forth on Schedule 3(y), the Company and its Subsidiaries own or
possess adequate rights or licenses to use all trademarks, trade names, service marks, service mark registrations, service names, original
works of authorship, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and
other intellectual property rights and all applications and registrations therefor (“Intellectual Property Rights”)
necessary to conduct their respective businesses as now conducted.  The Company does not have any knowledge of any infringement by
the Company or its Subsidiaries of Intellectual Property Rights of others.  There is no claim, action or proceeding being made or
brought, or to the knowledge of the Company or any of its Subsidiaries, being threatened, against the Company or any of its Subsidiaries
regarding its Intellectual Property Rights, except where such claim, action or proceeding is not reasonably likely to result in a Material
Adverse Effect.  Neither the Company nor any of its Subsidiaries has received any notice alleging any such infringement or claim,
action or proceeding.


 


(z)   Environmental Laws.  (i) The Company and its Subsidiaries (A) are in compliance with any and all Environmental
Laws (as defined below), (B) have received all permits, licenses or other approvals required of them under applicable Environmental
Laws to conduct their respective businesses and (C) are in compliance with all terms and conditions of any such permit, license or
approval where, except in each of the foregoing clauses (A), (B) and (C), where the failure to so comply or having such permits,
licenses or other approval would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 
The term “Environmental Laws” means all federal, state, local or foreign laws relating to pollution or protection of
human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata),
including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.


 






    	 	12	 



     


    

 


(i)   No Hazardous Materials:


 


(A)  to the Company’s knowledge, have been disposed of or otherwise released from any Real Property of the Company or any of its
Subsidiaries in violation of any Environmental Laws; or


 


(B)   to the Company’s knowledge, are present on, over, beneath, in or upon any Real Property or any portion thereof in quantities
that would constitute a violation of any Environmental Laws.  No prior use by the Company or any of its Subsidiaries of any Real
Property has occurred that violates any Environmental Laws, which violation would have a material adverse effect on the business of the
Company or any of its Subsidiaries.


 


(ii)  To the Company’s knowledge, neither the Company nor any of its Subsidiaries knows of any other person who or entity which
has stored, treated, recycled, disposed of or otherwise located on any Real Property any Hazardous Materials, including, without limitation,
such substances as asbestos and polychlorinated biphenyls.


 


(iii)  To the knowledge of the Company, none of the Real Property is on any federal or state “Superfund” list or Liability
Information System (“CERCLIS”) list or any state environmental agency list of sites under consideration for CERCLIS,
nor subject to any environmental related Liens.


 


(aa)  Tax Status.  The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state
income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject through the date of this
Agreement or have requested extensions thereof (except where the failure to file would not, individually or in the aggregate, have a Material
Adverse Effect) and (ii) has timely paid all taxes and other governmental assessments and charges that are material in amount, shown
or determined to be due on such returns, reports and declarations, except those being contested in good faith and for which reserves required
by GAAP have been created in the financial statements of the Company or for cases in which the failure to pay would not have a Material
Adverse Effect.  There is no tax deficiency that has been determined adversely to the Company or any of its Subsidiaries which has
had a Material Adverse Effect, nor does the Company or its Subsidiaries have any knowledge or notice of any tax deficiency which could
reasonably be expected to be determined adversely to the Company or its Subsidiaries and which could reasonably be expected to have a
Material Adverse Effect.


 


(bb)  Internal Accounting and Disclosure Controls.  Except as disclosed in Schedule 3(bb), the Company and each of
its Subsidiaries maintains internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934
Act) that is effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with GAAP, including that (i) transactions are executed in accordance with management’s
general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in
conformity with GAAP and to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted
only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets and
liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect
to any difference.  Except as disclosed in Schedule 3(bb), the Company maintains disclosure controls and procedures (as such
term is defined in Rule 13a-15(e) under the 1934 Act) that are effective in ensuring that information required to be disclosed
by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported, within the
time periods specified in the rules and forms of the SEC, including, without limitation, controls and procedures designed to ensure
that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is accumulated and
communicated to the Company’s management, including its principal executive officer or officers and its principal financial officer
or officers, as appropriate, to allow timely decisions regarding required disclosure.  Except as disclosed in Schedule 3(bb)
or in the SEC Documents, since the filing of the Annual Report on Form 10-K for the year ended December 31, 2018, neither the Company
nor any of its Subsidiaries has received any notice or correspondence from any accountant, Governmental Entity or other Person relating
to any potential material weakness or significant deficiency in any part of the internal controls over financial reporting of the Company
or any of its Subsidiaries.


 






    	 	13	 



     


    

 


(cc)  Off Balance Sheet Arrangements.  There is no transaction, arrangement, or other relationship between the Company or
any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its
1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.


 


(dd)  Investment Company Status.  The Company is not, and upon consummation of the sale of the Securities will not be, an
 “investment company,” or a company controlled by an “investment company” as such term is defined in the Investment
Company Act of 1940, as amended.


 


(ee)   Acknowledgement Regarding Buyer’s Trading Activity.  It is understood and acknowledged by the Company that (i) following
the public disclosure of the transactions contemplated by the Transaction Documents, in accordance with the terms thereof, the Buyer has
not been asked by the Company or any of its Subsidiaries to agree, nor has the Buyer agreed with the Company or any of its Subsidiaries,
to desist from effecting any transactions in or with respect to (including, without limitation, purchasing or selling, long and/or short)
any securities of the Company, or “derivative” securities based on securities issued by the Company or to hold any of the
Securities for any specified term; (ii) the Buyer, and counterparties in “derivative” transactions to which the Buyer
is a party, directly or indirectly, presently may have a “short” position in the Common Stock which was established prior
to the Buyer’s knowledge of the transactions contemplated by the Transaction Documents; and (iii) the Buyer shall not be deemed
to have any affiliation with or control over any arm’s length counterparty in any “derivative” transaction.  The
Company further understands and acknowledges that following the public disclosure of the transactions contemplated by the Transaction
Documents pursuant to the Press Release (as defined below) the Buyer may engage in hedging and/or trading activities (including, without
limitation, the location and/or reservation of borrowable shares of Common Stock) at various times during the period that the Securities
are outstanding. The Company acknowledges that such aforementioned hedging and/or trading activities do not constitute a breach of this
Agreement, the Bridge Notes or any other Transaction Document or any of the documents executed in connection herewith or therewith.


 






    	 	14	 



     


    

 


(ff)  Manipulation of Price.  Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company,
no Person acting on their behalf has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the
Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, (iii) paid
or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company or any of its Subsidiaries
or (iv) paid or agreed to pay any Person for research services with respect to any securities of the Company or any of its Subsidiaries.


 


(gg)  U.S. Real Property Holding Corporation.  Neither the Company nor any of its Subsidiaries is or has ever been, and so
long as any of the Securities are held by the Buyer, shall become, a U.S. real property holding corporation within the meaning of Section 897(c)(2)
of the Code, and the Company and each Subsidiary shall so certify upon the Buyer’s request.


 


(hh)  Transfer Taxes.  All present or future transfer, stamp, registration, court or documentary, recording, filing or other
similar taxes (other than taxes imposed on or measured by net income (however denominated)) which are required to be paid by the Company
in connection with the issuance, registration, sale or transfer of the Securities to be sold to the Buyer hereunder will be, or will have
been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied with in all material
respects.


 


(ii)  Bank Holding Company Act.  Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act
of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal
Reserve”).  Neither the Company nor any of its Subsidiaries owns or controls, directly or indirectly, five percent (5%)
or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve.  Neither the Company nor any of its Subsidiaries
exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation
by the Federal Reserve.


 


(jj)  Illegal or Unauthorized Payments; Political Contributions.  Neither the Company nor any of its Subsidiaries nor, to
the best of the Company’s knowledge (after reasonable inquiry of its officers and directors), any of the officers, directors, employees,
agents or other representatives of the Company or any of its Subsidiaries or affiliates, has, directly or indirectly, made or authorized
any payment, contribution or gift of money, property, or services, whether or not in contravention of applicable law, (i) as a kickback
or bribe to any Person or (ii) to any political organization, or the holder of or any aspirant to any elective or appointive public
office to influence official action or secure an improper advantage, except for personal political contributions not involving the direct
or indirect use of funds of the Company or any of its Subsidiaries.


 






    	 	15	 



     


    

 


(kk)   Money Laundering.  The operations of the Company and its Subsidiaries are and have been conducted at all times in material
compliance with the USA Patriot Act of 2001 and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including,
without limitation, the laws, regulations and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets
Control, including, but not limited, to (i) Executive Order 13224 of September 23, 2001 entitled, “Blocking Property and
Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism” (66 Fed. Reg. 49079 (2001)); and (ii) any
regulations contained in 31 CFR, Subtitle B, Chapter V.


 


(ll)     Management.  During the past five-year period, no current or former officer or director, to the knowledge of the Company,
has been the subject of:


 


(i)  a petition under bankruptcy laws or any other insolvency or moratorium law or the appointment by a court of a receiver, fiscal
agent or similar officer for such Person, or any partnership in which such person was a general partner at or within two years before
the filing of such petition or such appointment, or any corporation or business association of which such person was an executive officer
at or within two years before the time of the filing of such petition or such appointment;


 


(ii)  a conviction in a criminal proceeding or a named subject of a pending criminal proceeding (excluding traffic violations that do
not relate to driving while intoxicated or driving under the influence);


 


(iii)  any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently
or temporarily enjoining any such person from, or otherwise limiting, the following activities:


 


(1)  Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker,
leverage transaction merchant, any other person regulated by the United States Commodity Futures Trading Commission or an associated person
of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director
or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct
or practice in connection with such activity;


 


(2)  Engaging in any particular type of business practice; or


 


(3)  Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation
of securities laws or commodities laws;


 


(iv)  any order, judgment or decree, not subsequently reversed, suspended or vacated, of any authority barring, suspending or otherwise
limiting for more than sixty (60) days the right of any such person to engage in any activity described in the preceding sub paragraph,
or to be associated with persons engaged in any such activity;


 






    	 	16	 



     


    

 


(v)    a finding by a court of competent jurisdiction in a civil action or by the SEC or other authority to have violated any securities
law, regulation or decree and the judgment in such civil action or finding by the SEC or any other authority has not been subsequently
reversed, suspended or vacated; or


 


(vi)   a finding by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated
any federal commodities law, and the judgment in such civil action or finding has not been subsequently reversed, suspended or vacated.


 


(mm)  Stock Option Plans.  Each stock option granted by the Company was granted (i) in accordance with the terms of
the applicable stock option plan of the Company and (ii) with an exercise price at least equal to the fair market value of the Common
Stock on the date such stock option would be considered granted under GAAP and applicable law.  To the Company’s knowledge,
no stock option granted under the Company’s stock option plan has been backdated.  To the Company's knowledge, the Company
has not granted, and there is no and has been no policy or practice of the Company to grant, stock options prior to, or otherwise coordinate
the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries
or their financial results or prospects.


 


(nn)   [RESERVED]. 


 


(oo)   Compliance with Data Privacy Laws.  The Company and its Subsidiaries are, and at all prior times were, in material
compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and
the Company and its Subsidiaries have taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, have been
and currently are in compliance with, the GDPR (EU 2016/679) (collectively, the “Privacy Laws”). To ensure compliance
with the Privacy Laws, the Company and its Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to
ensure compliance in all material respects with their policies and procedures relating to data privacy and security and the collection,
storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company and its Subsidiaries
have at all times made all disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none
of such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in violation of any applicable
laws and regulatory rules or requirements in any material respect. To the Company's knowledge, neither the Company nor any Subsidiary:
(i) has received notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy
Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is currently
conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law;
or (iii) is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law.


 


(pp)   No Disqualification Event.  With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b)
under the 1933 Act (“Regulation D Securities”), none of the Company, any of its predecessors, any affiliated issuer,
any director, executive officer, other officer of the Company participating in the offering contemplated hereby, or, to the Company’s
knowledge, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of
voting power, nor any promoter (as that term is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at
the time of sale (each, an “Issuer Covered Person” and, together, “Issuer Covered Persons”) is subject
to any Disqualification Event, except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable
care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable,
with its disclosure obligations under Rule 506(e), and has furnished to the Buyers a copy of any disclosures provided thereunder.


 






    	 	17	 



     


    

 


(qq)   Other Covered Persons.  Except for FTI Consulting, the Company is not aware of any Person that has been or will be
paid (directly or indirectly) remuneration for solicitation of Buyer or potential purchasers in connection with the sale of any Regulation
D Securities.


 


(rr)     No Additional Agreements.  The Company does not have any agreement or understanding with any Buyer with respect to
the transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents.


 


(ss)    Disclosure.  The Company confirms that neither it nor any other Person acting on its behalf has provided the Buyer
or its agents or counsel with any information that constitutes or could reasonably be expected to constitute material, non-public information
concerning the Company or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the
other Transaction Documents.  The Company understands and confirms that the Buyer will rely on the foregoing representations in effecting
transactions in securities of the Company.  The Company acknowledges and agrees that the Buyer makes no nor has made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 2. Except for
the representations and warranties contained in this Section 3 (including the related portions of the disclosure schedules), neither the
Company nor any other Person has made or makes any other express or implied representation or warranty, either written or oral, on behalf
of the Company.


 


		4.	COVENANTS.



 


(a)     Blue Sky.  Without limiting any other obligation of the Company under this Agreement, the Company shall timely make
all filings and reports relating to the offer and sale of the Securities required under all applicable securities laws (including, without
limitation, all applicable federal securities laws and all applicable “Blue Sky” laws), and the Company shall comply with
all applicable foreign, federal, state and local laws, statutes, rules, regulations and the like relating to the offering and sale of
the Securities to the Buyer.


 


(b)     [RESERVED]


 


(c)     Use of Proceeds.  The Company will use the net proceeds from the sale of the Securities for general corporate purposes
in accordance with DIP budget circulated as of the date hereof (the “DIP Budget”), but not, directly or indirectly,
for (i) the redemption or repurchase of any securities of the Company or any of its Subsidiaries or repayment of any Indebtedness or (ii)
the settlement of any outstanding litigation.


 






    	 	18	 



     


    

 


(d)     [RESERVED]


 


(e)     [RESERVED]


 


(f)      Fees. The Company shall pay for the reasonable documented due diligence and legal fees and expenses incurred by the
Buyer in connection with the documentation, negotiation, and closing of the transactions contemplated by the Transaction Documents, including,
without limitation, all reasonable legal fees and disbursements of the Buyer, and due diligence and regulatory filings in connection therewith
(the “Transaction Expenses”) and such Transaction Expenses, to the extent they have not already been paid, may be withheld
by the Buyer from its Purchase Price at the Closing. The Company shall pay, and hold the Buyer harmless against, any liability, loss or
expense (including, without limitation, reasonable attorneys’ fees and reasonable and documented out-of-pocket expenses) arising
in connection with any claim relating to any such payment.  Except as otherwise set forth in the Transaction Documents, each party
to this Agreement shall bear its own expenses in connection with the sale of the Securities to the Buyer.


 


(g)    Pledge of Securities.  Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges
and agrees that the Securities may be pledged by a Buyer in connection with a bona fide margin agreement or other loan or financing arrangement
that is secured by the Securities.  The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities
hereunder, and the Buyer effecting a pledge of Securities shall not be required to provide the Company with any notice thereof or otherwise
make any delivery to the Company pursuant to this Agreement or any other Transaction Document, including, without limitation, Section
2(g) hereof; provided that the Buyer and its pledgee shall be required to comply with the provisions of Section 2(g) hereof in order to
effect a sale, transfer or assignment of Securities to such pledgee.  The Company hereby agrees to execute and deliver such documentation
as such pledgee of the Securities may reasonably request in connection with a pledge of the Securities to such pledgee by the Buyer.


 


(h)    Disclosure of Transactions and Other Material Information.


 


(i)   Disclosure of Transaction.  No later than 5:30 p.m., New York time, on the fourth (4th) Business Day after the date
of this Agreement, the Company shall file a Current Report on Form 8-K describing all the material terms of the transactions contemplated
by the Transaction Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (the “8-K
Filing”).  From and after the issuance of the Press Release, the Company shall have disclosed all material, non-public
information (if any) provided to the initial Buyer by the Company or any of its Subsidiaries or any of their respective officers, directors,
employees or agents in connection with the transactions contemplated by the Transaction Documents.  In addition, effective upon the
issuance of the Press Release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement,
whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees
or agents, on the one hand, and any of the Buyers or any of their affiliates, on the other hand, shall terminate.


 






    	 	19	 



     


    

 


(ii)   Limitations on Disclosure.  Other than as required under the Transaction Documents (but subject to any other disclosure
obligations of the Company with respect thereto), the Company shall not, and the Company shall cause each of its Subsidiaries and each
of its and their respective officers, directors, employees and agents not to, provide the initial Buyer with any material, non-public
information regarding the Company or any of its Subsidiaries from and after the date hereof unless prior thereto such Buyer shall have consented
in writing to the receipt of such information and agreed with the Company to keep such information confidential.  To the extent that
the Company delivers any material, non-public information to the initial Buyer without such Buyer’s prior written consent, the Company
hereby covenants and agrees that such Buyer shall not have any duty of confidentiality with respect to, or a duty not to trade on the
basis of, such material, non-public information, provided that such Buyer shall remain subject to applicable law.  Subject to the
foregoing, neither the Company, its Subsidiaries nor any Buyer shall issue any press releases or any other public statements with respect
to the transactions contemplated hereby; provided, however, the Company shall be entitled, without the prior approval of any Buyer, to
make the Press Release and any press release or other public disclosure with respect to such transactions (i) in substantial conformity
with the 8-K Filing and contemporaneously therewith and (ii) as is required by applicable law and regulations (provided that in the
case of clause (i) above, the initial Buyer shall be consulted (but shall not have a consent right) by the Company in connection
with any such press release or other public disclosure prior to its release).  Without the prior written consent of the applicable
Buyer (which may be granted or withheld in such Buyer’s sole discretion), the Company shall not (and shall cause each of its Subsidiaries
and affiliates to not) disclose the name of such Buyer in any filing, announcement, release or otherwise, except in the 8-K filing and
as otherwise may be required by applicable law.  Notwithstanding anything contained in this Agreement to the contrary and without
implication that the contrary would otherwise be true, the Company expressly acknowledges and agrees that no Buyer shall have (unless
expressly agreed to by a particular Buyer after the date hereof in a written definitive and binding agreement executed by the Company
and such particular Buyer (it being understood and agreed that no Buyer may bind any other Buyer with respect thereto)), any duty of confidentiality
with respect to, or a duty not to trade on the basis of, any material, non-public information regarding the Company or any of its Subsidiaries.


 


(i)  Additional Issuance of Securities. 


 


(i)  So long as any Bridge Notes remain outstanding, the Company will not, without the prior written consent of the Required Holders
(as defined below), issue any Convertible Notes, Bridge Notes or Warrants (other than to issue Bridge Notes to the Buyer as contemplated
hereby) and the Company shall not issue any other securities that would cause a breach or default under the Bridge Notes. The Company
agrees with the initial Buyer that for the period commencing on the date hereof and ending on the date immediately following the date
upon which the Company has for the prior 90 calendar day period filed the financial statement restatements set forth on Schedule
3(k) and all reports, schedules, forms, proxy statements, statements and other documents required to be filed by it with the SEC (other
than Section 16 ownership filings) pursuant to the reporting requirements of the 1934 Act (reports filed in compliance with the time period
specified in Rule 12b-25 promulgated under the 1934 Act shall be considered timely for this purpose) (the “Restricted Period”),
neither the Company nor any of its Subsidiaries shall directly or indirectly (i) issue, offer, sell, grant any option or right to purchase,
or otherwise dispose of (or announce any issuance, offer, sale, grant of any option or right to purchase or other disposition of) any
equity security or any equity-linked or related security (including, without limitation, any “equity security” (as that term
is defined under Rule 405 promulgated under the 1933 Act), any Convertible Securities, any preferred stock or any purchase rights)
(any such issuance, offer, sale, grant, disposition or announcement (whether occurring during the Restricted Period or at any time thereafter)
is referred to as a “Subsequent Placement”) or (ii) submit or file any registration statement under the 1933 Act in
respect of any of the foregoing.  Notwithstanding the foregoing, this Section 4(i)(i) shall not apply during the Restricted
Period in respect of the issuance of Excluded Securities (as defined in the Convertible Notes). 


 






    	 	20	 



     


    

 


(j)     [RESERVED]


 


(k)    Passive Foreign Investment Company.  The Company shall conduct its business, and shall cause its Subsidiaries to conduct
their respective businesses, in such a manner so as will ensure that the Company will not be deemed to constitute a passive foreign investment
company within the meaning of Section 1297 of the Code.


 


(l)     Corporate Existence.  So long as any Bridge Notes remain outstanding, the Company shall not be party to any Fundamental
Change (as defined in the Bridge Notes) unless the Company is in compliance with the applicable provisions governing Fundamental Changes
set forth in the Bridge Notes.


 


(m)   [RESERVED]


 


(n)    Regulation M.  The Company will not take any action prohibited by Regulation M under the 1934 Act, in connection with
the distribution of the Securities contemplated hereby.


 


(o)    General Solicitation.  None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act) or
any person acting on behalf of the Company or such affiliate will solicit any offer to buy or offer or sell the Securities by means of
any form of general solicitation or general advertising within the meaning of Regulation D, including: (i) any advertisement, article,
notice or other communication published in any newspaper, magazine or similar medium or broadcast over television or radio; and (ii) any
seminar or meeting whose attendees have been invited by any general solicitation or general advertising.


 


(p)    Integration.  None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act),
or any person acting on behalf of the Company or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise negotiate
in respect of any security (as defined in the 1933 Act) which will be integrated with the sale of the Securities in a manner which would
require the registration of the Securities under the 1933 Act or require stockholder approval under the rules and the Company will
take all action that is appropriate or necessary to assure that its offerings of other securities will not be integrated for purposes
of the 1933 Act, with the issuance of Securities contemplated hereby.


 


(q)    [RESERVED]


 






    	 	21	 



     


    

 


(r)     [RESERVED]


 


(s)    [RESERVED]


 


(t)     [RESERVED]


 


(u)    Tax Certification.


 


(i)   The Buyer, or its assignee or transferee (as the case may be) that is entitled to an exemption from or reduction of withholding
Tax with respect to payments made pursuant to the Securities shall deliver to the Company, at the time or times reasonably requested by
the Company, such properly completed and executed documentation reasonably requested by the Company as will permit such payments to be
made without withholding or at a reduced rate of withholding. In addition, the Buyer, or its assignee or transferee (as the case may be)
or, if reasonably requested by the Company, shall deliver such other documentation prescribed by applicable law or reasonably requested
by the Company as will enable the Company to determine whether or not the Buyer, assignee or transferee (as the case may be) is subject
to backup withholding. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission
of such documentation (other than such documentation set forth in Section 4(u)(ii)) shall not be required if in the reasonable judgement
of the Buyer, assignee or transferee (as the case may be) such completion, execution or submission would subject the Buyer, assignee or
transferee (as the case may be) to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position
of such Buyer, assignee or transferee (as the case may be).


 


(ii)  Without limiting the generality of the foregoing, (i) the Buyer, its assignee or transferee (as the case may be) that is a United
States person (within the meaning of Section 7701(a)(30) of the Code) shall deliver to the Company (upon the reasonable request of the
Company), executed originals of IRS Form W-9 certifying that such Buyer, assignee or transferee (as the case may be) is exempt from U.S.
federal backup withholding tax; (ii) the Buyer, assignee or its transferee (as the case may be) that is not a United States person (within
the meaning of Section 7701(a)(30) of the Code) shall deliver to the Company (upon the reasonable request of the Company) whichever of
the following is applicable: (x) executed originals of IRS Form W-8BEN or IRS Form W-8BENE, as applicable, establishing an exemption from,
or reduction of, U.S. federal withholding Tax, (y) executed originals of IRS Form W-8ECI, and (z) to the extent such Buyer, assignee or
transferee (as the case may be) is not the beneficial owner, executed originals of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS
Form W-8BEN, IRS Form W-9 and/or other certification documents from each beneficial owner, as applicable, and (iii) if a payment made
to the Buyer, assignee or transferee (as the case may be) would be subject to U.S. federal withholding Tax imposed by FATCA if such Buyer,
assignee or transferee were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section
1471(b) or 1472(b) of the Code, as applicable), the Buyer, assignee or transferee (as the case may be) shall deliver to the Company at
the time or times prescribed by law and at such time or times reasonably requested by the Company such documentation prescribed by applicable
law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Company
as may be necessary for the Company to comply with its obligations under FATCA and to determine that such Buyer, assignee or transferee
has complied with the obligations of such Buyer, assignee or transferee (as the case may be) under FATCA or to determine the amount to
deduct and withholding from such payment.


 






    	 	22	 



     


    

 


(iii)   For purposes of this Agreement, “FATCA” means Sections 1471 through 1474 of the Code, as amended from time to
time, any current or future regulations or official interpretations thereof and any agreements entered into pursuant to Section 1471(b)(1)
of the Code.


 


(iv)   The Buyer, its assignee or transferee (as the case may be) agrees that if any form or certification it previously delivered expires
or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Company in writing
of its legal inability to do so.


 


		5.	REGISTER.



 


(a)    Register.  The Company shall maintain at its principal executive offices (or such other office or agency of the Company
as it may designate by notice to each holder of Securities), a register for the Securities in which the Company shall record the name
and address of the Person in whose name the Purchased Securities have been issued (including the name and address of each transferee)
and the aggregate number of the Bridge Notes held by such Person.  The Company shall keep the register open and available at all
times during business hours for inspection of the Buyer or its legal representatives.


 


(b)    [RESERVED]


 


(c)    Legend.  The Buyer understands that the Securities have been issued pursuant to an exemption from registration or qualification
under the 1933 Act and applicable state securities laws, and except as set forth herein, the Securities shall bear any legend as required
by the “blue sky” laws of any state and a restrictive legend in substantially the following form (and a stop-transfer order
may be placed against transfer of such stock certificates):


 


Bridge Note Legend


 


THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
AND PROSPECTUS-DELIVERY REQUIREMENTS OF THE SECURITIES ACT.


 






    	 	23	 



     


    

 


(d)    Removal of Legends.


 


(i) Certificates evidencing Securities shall not be required to contain the legend set forth in Section 5(c) above or any other legend
(A) while a registration statement covering the resale of such Securities is effective under the 1933 Act, (B) following any sale of such
Securities pursuant to Rule 144 (assuming the transferor is not an affiliate of the Company), provided that the Buyer furnishes the Company
with reasonable assurances that such Securities are eligible for sale, assignment or transfer under Rule 144, which shall not include
an opinion of Buyer’s counsel, (C) in connection with a sale, assignment or other transfer (other than under Rule 144), provided
that the Buyer provides the Company with an opinion of counsel to the Buyer with expertise in U.S. federal securities laws, in a reasonably
acceptable form, to the effect that such sale, assignment or transfer of the Securities may be made without registration under the applicable
requirements of the 1933 Act or (D) if such legend is not required under applicable requirements of the 1933 Act (including, without limitation,
controlling judicial interpretations and pronouncements issued by the SEC). If a legend is not required pursuant to the foregoing, the
Company shall no later than two (2) Business Days (or such earlier date as required pursuant to the 1934 Act or other applicable law,
rule or regulation for the settlement of a trade initiated on the date the Buyer delivers such legended certificate representing such
Securities to the Company) following the delivery by the Buyer to the Company or the Transfer Agent (with notice to the Company) of a
legended certificate representing such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form
necessary to affect the reissuance and/or transfer, if applicable), together with any other deliveries from the Buyer as may be reasonably
required above in this Section 5(d), as directed by such Buyer, either: (A) provided that the Transfer Agent is participating in the DTC
Fast Automated Securities Transfer Program and such Securities are Underlying Shares, credit the aggregate number of shares of Common
Stock to which such Buyer shall be entitled to such Buyer’s or its designee’s balance account with DTC through its Deposit/Withdrawal
at Custodian system or (B) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and
deliver (via reputable overnight courier) to such Buyer, a certificate representing such Securities that is free from all restrictive
and other legends, registered in the name of the Buyer or its designee. The Company shall be responsible for any transfer agent fees or
DTC fees with respect to any issuance of Securities or the removal of any legends with respect to any Securities in accordance herewith
and the Buyer shall not be required to deliver or cause to be delivered a legal opinion in connection with a sale of such Securities pursuant
to Rule 144.


 


(ii)  [RESERVED]


 


(e)  FAST Compliance.  While any Bridge Notes remain outstanding, the Company shall maintain a transfer agent that participates
in the DTC Fast Automated Securities Transfer Program.


 


		6.	MISCELLANEOUS.



 


(a)   Governing Law; Jurisdiction; Jury Trial.  All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws
of any jurisdictions other than the State of New York.  The Company hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection
herewith or under any of the other Transaction Documents or with any transaction contemplated hereby or thereby, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law.  Nothing contained herein shall be deemed or operate
to preclude the Buyer from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the
Company’s obligations to the Buyer or to enforce a judgment or other court ruling in favor of the Buyer.  EACH PARTY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR UNDER ANY OTHER TRANSACTION DOCUMENT OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT OR ANY
TRANSACTION CONTEMPLATED HEREBY OR THEREBY.


 






    	 	24	 



     


    

 


(b)    Counterparts.  This Agreement may be executed in two or more identical counterparts, all of which shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. 
In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf)
file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on
whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.


 


(c)    Headings; Gender.  The headings of this Agreement are for convenience of reference and shall not form part of, or affect
the interpretation of, this Agreement.  Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include
the masculine, feminine, neuter, singular and plural forms thereof.  The terms “including,” “includes,” “include”
and words of like import shall be construed broadly as if followed by the words “without limitation.”  The terms “herein,”
 “hereunder,” “hereof” and words of like import refer to this entire Agreement instead of just the provision in
which they are found. Unless the context otherwise requires, references herein: (x) to Articles, Sections, Schedules and Exhibits mean
the Articles and Sections of, and Schedules and Exhibits attached to, this Agreement; (y) to an agreement, instrument or other document
means such agreement, instrument or other document as amended, supplemented and modified from time to time to the extent permitted by
the provisions thereof and (z) to a statute means such statute as amended from time to time and includes any successor legislation thereto
and any regulations promulgated thereunder.


 


(d)    Severability; Maximum Payment Amounts.  If any provision of this Agreement is prohibited by law or otherwise determined
to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable
shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability
of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified
continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited
nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. 
The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid
provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).  Notwithstanding
anything to the contrary contained in this Agreement or any other Transaction Document (and without implication that the following is
required or applicable), it is the intention of the parties that in no event shall amounts and value paid by the Company and/or any of
its Subsidiaries (as the case may be), or payable to or received by the Buyer, under the Transaction Documents (including without limitation,
any amounts that would be characterized as “interest” under applicable law) exceed amounts permitted under any applicable
law.  Accordingly, if any obligation to pay, payment made to the Buyer, or collection by the Buyer pursuant the Transaction Documents
is finally judicially determined to be contrary to any such applicable law, such obligation to pay, payment or collection shall be deemed
to have been made by mutual mistake of the Buyer, the Company and its Subsidiaries and such amount shall be deemed to have been adjusted
with retroactive effect to the maximum amount or rate of interest, as the case may be, as would not be so prohibited by the applicable
law.  Such adjustment shall be effected, to the extent necessary, by reducing or refunding, at the option of the Buyer, the amount
of interest or any other amounts which would constitute unlawful amounts required to be paid or actually paid to the Buyer under the Transaction
Documents.  For greater certainty, to the extent that any interest, charges, fees, expenses or other amounts required to be paid
to or received by the Buyer under any of the Transaction Documents or related thereto are held to be within the meaning of “interest”
or another applicable term to otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time to which
they relate.


 






    	 	25	 



     


    

 


(e)    Entire Agreement; Amendments.  This Agreement, the other Transaction Documents and the schedules and exhibits attached
hereto and thereto and the instruments referenced herein and therein supersede all other prior oral or written agreements among the Buyer,
the Company, its Subsidiaries, their affiliates and Persons acting on their behalf, including, without limitation, any transactions by
the Buyer with respect to Common Stock or the Securities, and the other matters contained herein and therein, and this Agreement, the
other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein
contain the entire understanding of the parties solely with respect to the matters covered herein and therein; provided, however, nothing
contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements
the Buyer has entered into with, or any instruments the Buyer has received from, the Company or any of its Subsidiaries prior to the date
hereof or (ii) waive, alter, modify or amend in any respect any obligations of the Company or any of its Subsidiaries, or any rights
of or benefits to the Buyer or any other Person, in any agreement entered into prior to the date hereof, between or among the Company
and/or any of its Subsidiaries and the Buyer, or any instruments the Buyer received from the Company and/or any of its Subsidiaries prior
to such applicable date, and all such agreements and instruments shall continue in full force and effect.  Except as specifically
set forth herein or therein, neither the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect
to such matters.  For clarification purposes, the Recitals are part of this Agreement.  No provision of this Agreement or any
Security Document may be amended other than by an instrument in writing signed by the Company and the Required Holders, and any amendment
to any provision of this Agreement or any Security Document made in conformity with the provisions of this Section 6(e) shall
be binding on the Buyer and holders of Securities, as applicable; provided that no such amendment shall be effective to the extent that
it (A) applies to less than all of the holders of the Securities then outstanding (or applies to any Bridge Note and is not also
applicable to all other Bridge Notes, without the prior written consent of the Required Bridge Holders (as defined below) (which may be
granted or withheld in the Required Bridge Holders’ sole discretion)) or (B) imposes any obligation or liability on the Buyer
without the Buyer’s prior written consent (which may be granted or withheld in the Buyer’s sole discretion).  No waiver
of any requirement of this Agreement or any Security Document shall be effective unless it is in writing and signed by an authorized representative
of the waiving party, provided that the Required Holders may waive any provision of this Agreement or any Security Document, and any waiver
of any provision of this Agreement or any Security Document made in conformity with the provisions of this Section 6(e) shall
be binding on the Buyers and holders of Securities, as applicable, provided that no such waiver shall be effective to the extent that
it (1) applies to less than all of the holders of the Securities then outstanding (unless a party gives a waiver as to itself only
(or in the case of any application to any Bridge Note that is not also applicable to all other Bridge Notes, the Required Bridge Holders
have given their prior written consent))) or (2) imposes any obligation or liability on the Buyer without the Buyer’s prior
written consent (which may be granted or withheld in the Buyer’s sole discretion).  Notwithstanding the forgoing, Section 5.11
of the Security Agreement may not be amended, waived or otherwise modified without the prior written consent of the Required Bridge Holders.
No consideration (other than reimbursement of legal fees) shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of any of the Transaction Documents unless the same consideration also is offered to all of the parties to the Transaction
Documents and all holders of the Purchased Securities.  As a material inducement for the Buyer to enter into this Agreement, the
Company expressly acknowledges and agrees that (x) no due diligence or other investigation or inquiry conducted by the Buyer, any
of its advisors or any of its representatives shall affect the Buyer’s right to rely on, or shall modify or qualify in any manner
or be an exception to any of, the Company’s representations and warranties contained in this Agreement or any other Transaction
Document and (y) nothing contained in any of the SEC Documents shall affect the Buyer’s right to rely on, or shall modify or qualify
in any manner or be an exception to any of, the Company’s representations and warranties contained in this Agreement or any other
Transaction Document.  “Required Holders” as of any time means holders of a majority of the principal amount of
the Bridge Notes as of such time issued hereunder.


  


(f)  Notices.  Any notices, consents, waivers or other communications required or permitted to be given under the terms
of this Agreement must be in writing and will be deemed to have been delivered:  (i) upon receipt, when delivered personally;
(ii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and
kept on file by the sending party) or electronic mail (provided that such sent email is kept on file (whether electronically or otherwise)
by the sending party and the sending party does not receive an automatically generated message from the recipient’s email server
that such e-mail could not be delivered to such recipient); or (iii) one (1) Business Day after deposit with an overnight courier
service with next day delivery specified, in each case, properly addressed to the party to receive the same.  The addresses, facsimile
numbers and e-mail addresses for such communications shall be:


 






    	 	26	 



     


    

 


If to the Company:


 


Pareteum Corporation,

1185 Avenue of the Americas, 2nd Floor

New York, NY 10036


 


Telephone:  (212) 984-1096

Facsimile:  N/A

Attention:  Laura Thomas, Interim Chief Financial Officer

E-Mail:  laura.thomas@pareteum.com; legal@pareteum.com


 


With a copy (for informational purposes only) to:


 


McGuireWoods LLP


1251 Avenue of the Americas, 20th Floor


New York, NY 10020-1104


 


Telephone: (212) 548-2122


Facsimile: (212) 715-2307


Attention: Stephen E. Older, Esq.


E-mail: solder@mcguirewoods.com


 


If to the Transfer Agent:


 


Continental Stock Transfer & Trust Company


1 State Street, Floor 30


New York, NY 10004


 


Telephone:  (212) 845-3217

Facsimile:  (212) 616-7616

Attention:  Michael Mullings

E-Mail:  oplink@continentalstock.com 


  


If to the Buyer, to (i) its e-mail address set
forth on the Schedule of Buyers, with copies to such Buyer’s representatives as set forth on the Schedule of Buyers and (ii) to
Legal, Circles MVNE Pte. Ltd., 221 Henderson Rd #06-10, Henderson Building, Singapore 159557 (legal@circles.asia),


 


with a copy (for informational purposes only) to:


 


DLA Piper LLP (US)

1251 Avenue of the Americas

New York, NY 10020

Telephone:  (212) 335-4500

Facsimile:  (212) 335-4501

Attention:  Jamila Justine Willis, Esq., Shmuel Klahr, Esq.

E-mails:  jamila.willis@us.dlapiper.com; shmuel.klahr@us.dlapiper.com


 



    	 	27	 



     


    

 





or to such other address, e-mail address and/or
facsimile number and/or to the attention of such other Person as the recipient party has specified by written notice given to each other
party five (5) days prior to the effectiveness of such change.  Written confirmation of receipt (A) given by the recipient
of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s facsimile
machine or e-mail containing the time, date, recipient facsimile number and, with respect to each facsimile transmission, an image of
the first page of such transmission or (C) provided by an overnight courier service shall be rebuttable evidence of personal
service, receipt by facsimile or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above,
respectively.


 


(g)   Successors and Assigns.  This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and assigns, including any purchasers of any of the Purchased Securities.  The Company shall not assign this Agreement
or any rights or obligations hereunder without the prior written consent of the Required Holders, including, without limitation, by way
of a Fundamental Change (as defined in the Bridge Notes) (unless the Company is in compliance with the applicable provisions governing
Fundamental Changes set forth in the Bridge Notes).  The Buyer may assign some or all of its rights hereunder in connection with
any transfer of any of its Securities to any of its affiliates without the consent of the Company, provided such assignee agrees in writing
to be bound by the provisions hereof that apply to the Buyer in which event such assignee shall be deemed to be a Buyer hereunder with
respect to such assigned rights.


 


(h)   No Third-Party Beneficiaries.  This Agreement is intended for the benefit of the parties hereto and their respective
permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other
than the Indemnitees referred to in Section 6(k). 


 


(i)    Survival.  The representations, warranties, agreements and covenants shall survive the Closing. 


 


(j)    Further Assurances.  Each party shall do and perform, or cause to be done and performed, all such further acts and
things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.


 


(k)   Indemnification. 


 


(i)   In consideration of the Buyer’s execution and delivery of the Transaction Documents and acquiring the Securities thereunder
and in addition to all of the Company’s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify
and hold harmless the Buyer and each holder of any Securities and all of their stockholders, partners, members, officers, directors, employees
and direct or indirect investors and any of the foregoing Persons’ agents or other representatives (including, without limitation,
those retained in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought),
and including reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by any Indemnitee
as a result of, or arising out of, or relating to (i) any misrepresentation or breach of any representation or warranty made by the
Company or any Subsidiary in any of the Transaction Documents, (ii) any breach of any covenant, agreement or obligation of the Company
or any Subsidiary contained in any of the Transaction Documents or (iii) any cause of action, suit, proceeding or claim brought or
made against such Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company or any
Subsidiary) or which otherwise involves such Indemnitee that arises out of or results from (A) the execution, delivery, performance
or enforcement of any of the Transaction Documents, or (B) the status of the Buyer or holder of the Securities either as an investor
in the Company pursuant to the transactions contemplated by any of the Transaction Documents or as a party to this Agreement (including,
without limitation, as a party in interest or otherwise in any action or proceeding for injunctive or other equitable relief); provided,
however, that the Company will not be liable in any such case to the extent that any such claim, loss, damage, liability or expense arise
primarily out of or is based primarily upon the inaccuracy of any representations and warranties made by such Buyer herein.  To the
extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law. 


 






    	 	28	 



     


    

 


(ii)  Promptly after receipt by an Indemnitee under this Section 6(k) of notice of the commencement of any action or proceeding (including,
without limitation, any governmental action or proceeding) involving an Indemnified Liability, such Indemnitee shall, if a claim in respect
thereof is to be made against any indemnifying party under this Section 6(k), deliver to the indemnifying party a written notice of the
commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so
desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory
to the indemnifying party and the Indemnitee; provided, however, that an Indemnitee shall have the right to retain its own counsel with
the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the indemnifying party has agreed in writing to pay
such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume the defense of such Indemnified Liability and
to employ counsel reasonably satisfactory to such Indemnitee in any such Indemnified Liability; or (iii) the named parties to any such
Indemnified Liability (including, without limitation, any impleaded parties) include both such Indemnitee and the indemnifying party,
and such Indemnitee shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent
such Indemnitee and the indemnifying party (in which case, if such Indemnitee notifies the indemnifying party in writing that it elects
to employ separate counsel at the expense of the indemnifying party, then the indemnifying party shall not have the right to assume the
defense thereof and such counsel shall be at the expense of the indemnifying party), provided further that in the case of clause (iii)
above the indemnifying party shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel
for such Indemnitee. The Indemnitee shall reasonably cooperate with the indemnifying party in connection with any negotiation or defense
of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available
to the Indemnitee which relates to such Indemnified Liability. The indemnifying party shall keep the Indemnitee reasonably apprised at
all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for
any settlement of any action, claim or proceeding effected without its prior written consent; provided, however, the indemnifying party
shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the
Indemnitee, consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such Indemnitee of a release from all liability in respect to such Indemnified
Liability , and such settlement shall not include any admission as to fault on the part of the Indemnitee. Following indemnification as
provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnitee with respect to all third parties,
firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying
party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the
Indemnitee under this Section 6(k), except to the extent that the indemnifying party is materially and adversely prejudiced in its ability
to defend such action. The indemnification required by this Section 6(k) shall be made by periodic payments of the amount thereof during
the course of the investigation or defense, as and when bills are received or Indemnified Liabilities are incurred. The indemnity and
contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnitees against the
indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law. 


 






    	 	29	 



     


    

 


(l)   Construction.  The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.  No specific representation or warranty
shall limit the generality or applicability of a more general representation or warranty.  Each and every reference to share prices,
shares of Common Stock and any other numbers in this Agreement that relate to the Common Stock shall be automatically adjusted for any
stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions that occur with respect to the Common
Stock after the date of this Agreement.  Notwithstanding anything in this Agreement to the contrary, for the avoidance of doubt,
nothing contained herein shall constitute a representation or warranty against, or a prohibition of, any actions with respect to the borrowing
of, arrangement to borrow, identification of the availability of, and/or securing of, securities of the Company in order for the Buyer
(or its broker or other financial representative) to effect short sales or similar transactions in the future.


 


(m)  Remedies.  Each party and in the event of assignment by a party of its rights and obligations hereunder, each assignee,
shall have all rights and remedies set forth in the Agreement and all rights and remedies which such assignees have been granted at any
time under any other agreement or contract and all of the rights which such holders have under any law.  Any Person having any rights
under any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security),
to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law.  Furthermore,
the Company recognizes that in the event that it or any Subsidiary fails to perform, observe, or discharge any or all of its or such Subsidiary’s
(as the case may be) obligations under this Agreement, any remedy at law would be inadequate relief to the Buyer.  The Company therefore
agrees that the Buyer shall be entitled to specific performance and/or temporary, preliminary and permanent injunctive or other equitable
relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and without posting a
bond or other security.  The remedies provided in this Agreement and the other Transaction Documents shall be cumulative and in addition
to all other remedies available under this Agreement and the other Transaction Documents, at law or in equity (including a decree of specific
performance and/or other injunctive relief).


 



    	 	30	 



     


    




 


(n)   Withdrawal Right.  Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) this Agreement, whenever the Buyer exercises a right, election, demand or option under this Agreement and the Company or any Subsidiary
does not timely perform its related obligations within the periods therein provided, then the Buyer may rescind or withdraw, in its sole
discretion from time to time upon written notice to the Company or such Subsidiary (as the case may be), any relevant notice, demand or
election in whole or in part without prejudice to its future actions and rights.


 


(o)   Payment Set Aside; Currency.  To the extent that the Company makes a payment or payments to the Buyer hereunder or
pursuant to any of the other Transaction Documents or the Buyer enforces or exercises its rights hereunder or thereunder, and such payment
or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent
or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company,
a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state or federal law,
common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended
to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff
had not occurred.  Unless otherwise expressly indicated, all dollar amounts referred to in this Agreement and the other Transaction
Documents are in United States Dollars (“U.S. Dollars”), and all amounts owing under this Agreement and all other Transaction
Documents shall be paid in U.S. Dollars.  All amounts denominated in other currencies (if any) shall be converted into the U.S. Dollar
equivalent amount in accordance with the Exchange Rate on the date of calculation.  “Exchange Rate” means, in
relation to any amount of currency to be converted into U.S. Dollars pursuant to this Agreement, the U.S. Dollar exchange rate as published
in the Wall Street Journal on the relevant date of calculation.


 


(p)   Judgment Currency.


 


(i)   If for the purpose of obtaining or enforcing judgment against the Company in connection with this Agreement or any other Transaction
Document in any court in any jurisdiction it becomes necessary to convert into any other currency (such other currency being hereinafter
in this Section 6(p) referred to as the “Judgment Currency”) an amount due in U.S. Dollars under this Agreement,
the conversion shall be made at the Exchange Rate prevailing on the Business Day immediately preceding:


 






    	 	31	 



     


    

 


(1)   the date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other
jurisdiction that will give effect to such conversion being made on such date; or


 


(2)   the date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date
as of which such conversion is made pursuant to this Section 6(p)(i)(2) being hereinafter referred to as the “Judgment
Conversion Date”).


 


(ii)   If in the case of any proceeding in the court of any jurisdiction referred to in Section 6(p)(i)(2)  above, there is
a change in the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable
party shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the
Exchange Rate prevailing on the date of payment, will produce the amount of U.S. Dollars which could have been purchased with the amount
of Judgment Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.


 


(iii)   Any amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being
obtained for any other amounts due under or in respect of this Agreement or any other Transaction Document.


 


(q)   Independent Nature of Buyer’s Obligations and Rights.  The obligations of the Buyer under the Transaction Documents
are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance of
the obligations of any other Buyer under any Transaction Document.  Nothing contained herein or in any other Transaction Document,
and no action taken by any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company acknowledges
that the Buyers do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a
presumption that the Buyers are in any way acting in concert or as a group or entity, and the Company shall not assert any such claim
with respect to such obligations or the transactions contemplated by the Transaction Documents or any matters, and the Company acknowledges
that the Buyers are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or the transactions contemplated by the Transaction Documents.  The decision of each Buyer to purchase Securities pursuant to the
Transaction Documents has been made by such Buyer independently of any other Buyer.  Each Buyer acknowledges that no other Buyer
has acted as agent for such Buyer in connection with such Buyer making its investment hereunder and that no other Buyer will be acting
as agent of such Buyer in connection with monitoring such Buyer’s investment in the Securities or enforcing its rights under the
Transaction Documents.  The Company and each Buyer confirms that each Buyer has independently participated with the Company and its
Subsidiaries in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors.  Each Buyer
shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement
or out of any other Transaction Documents, and it shall not be necessary for any other Buyer to be joined as an additional party in any
proceeding for such purpose.  The use of a single agreement to effectuate the purchase and sale of the Securities contemplated hereby
was solely in the control of the Company, not the action or decision of any Buyer, and was done solely for the convenience of the Company
and its Subsidiaries and not because it was required or requested to do so by any Buyer.  It is expressly understood and agreed that
each provision contained in this Agreement and in each other Transaction Document is between the Company, each Subsidiary and a Buyer,
solely, and not between the Company, its Subsidiaries and the Buyers collectively and not between and among the Buyers.


  


(r)   Performance Date.  If the date by which any obligation under any of the Transaction Documents must be performed occurs
on a day other than a Business Day, then the date by which such performance is required shall be the next Business Day following such
date.


 


(s)  Enforcement Fees. The prevailing party shall have the right to collect from the other all costs and expenses incurred by
such prevailing party as a result of enforcement of this Agreement and the collection of any amounts owed to such prevailing party hereunder
(whether in cash, equity or otherwise), including, without limitation, reasonable attorneys’ fees and expenses.


 


[signature pages follow]


 




    	 	32	 



     


    


 


IN WITNESS WHEREOF, the Buyer and the Company
have caused their respective signature page to this Agreement to be duly executed as of the date first written above.


 


 


	 	COMPANY:
	 	 
	 	PARETEUM CORPORATION
	 	           

	 	 
	 	By: 	   /s/ Alexander Korff 
	 	 	Name: 	 Alexander Korff
	 	 	Title: 	 Corporate Secretary


  




     

     


    



 


IN WITNESS WHEREOF, the Buyer and the Company
have caused their respective signature page to this Agreement to be duly executed as of the date first written above.


 


	 	BUYER:
	 	           

	 	CIRCLES MVNE PTE. LTD.
	 	 
	 	 	 
	 	By:	 /s/ Chee Kiong Mak
	 	 	 	Chee Kiong Mak
	 	 	 	 Authorized Signatory


 


 


 


 




     

     


    



 


SCHEDULE OF BUYERS1


 


 


 


 


 





 



1
Amended and Restated in its entirety as provided in Exhibit B to Second Omnibus Amendment


 


 




     

     


    


 


Exhibit A 


 


Form of Senior Secured Bridge Note


 


[Intentionally omitted]


 


 


 


 




     

     


    


 


Exhibit B 


 


Form of Security Agreement


 


[Intentionally omitted]